Newswise — Abstract submission is now open for the Focused Ultrasound Foundation's Symposium, "Current and Future Applications of Focused Ultrasound 2014.” The Foundation welcomes abstracts related to preclinical, translational, or clinical research that involves the use of image-guided focused ultrasound. Topics of interest include treatments for the brain, bone, breast, liver, prostate, uterine fibroids, and other emerging applications.
Submissions must be entered online and will be accepted only through July 14, 2014. This date will not be extended as in past years.
Young Investigator AwardsThe Foundation also offers young investigator awards to clinicians and scientists-in-training, offering them the chance to attend the Symposium and present their data among leaders in the field.
Graduate students, research fellows, clinical fellows and junior faculty members are eligible to apply for the awards, which include complementary event registration and up to an additional $1,500 in reimbursement for travel and lodging expenses.
ABOUT THE SYMPOSIUMThe 2014 Symposium is the world's leading forum of clinical and scientific experts advancing the field of image-guided focused ultrasound. Taking place in Bethesda, Maryland, October 12-16, the conference will offer a multifaceted exploration of current and future applications of the technology and feature plenary sessions, panel discussions, poster presentations, and exhibits. Topics include the application of focused ultrasound to treat the brain, bone, breast, liver, prostate, uterus, and other emerging applications.
ABOUT FOCUSED ULTRASOUNDFocused ultrasound is a revolutionary, early-stage therapeutic technology with the potential to transform the treatment of many serious medical disorders. This breakthrough technology uses ultrasonic energy guided by magnetic resonance or ultrasound imaging to treat tissue deep in the body without incisions or radiation. Multiple intersecting beams of ultrasound are directed and concentrated on a target as small as a grain of rice, much like a magnifying glass can focus multiple beams of light on a single point.
Focused ultrasound is currently approved in the U.S. to treat uterine fibroids and painful bone metastases, and there are a growing number of clinical applications in various stages of research and development around the world, including Parkinson’s disease, essential tremor, neuropathic pain, breast and prostate cancer, and brain tumors.
ABOUT THE FOCUSED ULTRASOUND FOUNDATIONThe Focused Ultrasound Foundation was created to improve the lives of millions of people worldwide by accelerating the development and adoption of focused ultrasound therapies. The Foundation works to clear the path to global adoption by coordinating and funding research, fostering collaboration among stakeholders, and building awareness of the technology among patients and professionals. The Foundation is dedicated to ensuring that focused ultrasound finds its place as a mainstream therapy for a range of conditions within years, not decades. Since its establishment in 2006, the Foundation has become the largest non-governmental source of funding for focused ultrasound research. More information about the Charlottesville, Virginia-based Foundation can be found at www.fusfoundation.org.